eDruginfo.com
Wolters Kluwer | Lippencott Williams & Wilkins
Drug Warnings

   Drug Updates

   Patient Teaching

   Drug Warnings

   News Capsules

   Herbal Spotlight

   Quik Tools

   Drug Info Links

   Drug Info Bookstore

   Feedback

   Registration

   Disclaimer



propofol
Diprivan
  Pharmaceutical company:
Abraxis BioScience
www.appdrugs.com

NEW WARNING
The FDA issued an alert about several patients experiencing chills, fever, and body aches after receiving propofol for sedation or general anesthesia. Various lots of the drug have been tested but no toxins, bacteria or other signs of contamination were found. The FDA advises all health care providers to carefully follow the handling and use sections of the prescribing information for this drug. They recommend that all patients be evaluated for possible reactions after use of the drug and that anyone experiencing signs of acute febrile reactions be evaluated for possible bacterial sepsis. They ask that any adverse events following the use of propofol be reported to MedWatch.

     
   

Home - Guest Registry - Customer Service

Brought to you by Lippincott Williams & Wilkins.
For help on how you should use this site, see our
Disclaimer .

© Copyright 2008 by Lippincott Williams & Wilkins